
An options trade that wins if UnitedHealth bounces after its sharp sell-off
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Traders Pile on Short Positions as Bitcoin Approaches All-Time High
Crypto traders are exhibiting bearish behavior despite bitcoin BTC trading above $110,000 and possibly taking aim at a new record high above $112,000. Data from Coinalyze shows that during bitcoin's move this week from $106,000 to $110,000, the long/short ratio fell from 1.223 in favor of longs to 0.858 in favor of shorts. It's worth noting that the long/short ratio in this case is analyzing the percentage of accounts that are long or short, which is typically an indicator of retail sentiment. The long/short ratio has been negative numerous times during the recent move above $100,000 despite staying positive throughout the previous bull market in 2021. Open interest also rose from $32 billion to $35 billion during this period, indicating that significant capital is being pumped into shorting bitcoin. However, funding rates remained positive throughout this rise, indicating that traders are also entering long positions. Bitcoin has been trapped in a relatively tight range since early May, trading between $100,000 and $110,000 with three tests of each level of support and resistance. Technical indicators like relative strength index (RSI) continue to paint a bearish image with several drives of bearish divergence, with RSI weakening on each test of $110,000. The recent influx of short positions could well be lower timeframe traders capitalizing on the range, shorting resistance before reversing their trade at each test of $100,000. This rang true on June 22 when the long/short ratio shot up to 1.68 as bitcoin momentarily slumped through $100,000 before bouncing. There is a potential bull case with the increase in short positions: a short squeeze. This would occur if bitcoin begins to trigger liquidation points and stop losses above a record high, which would cause an impulse in buy pressure and continuation to the in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
8 hours ago
- Yahoo
UnitedHealth Under Fire as Medicaid & Centene Bombshell Rattle Sector
UnitedHealth Group Incorporated UNH continues to face challenges amid a turbulent healthcare insurance landscape. The passage of the 'One Big Beautiful Bill Act' through Congress, ready for President Donald Trump's signature, threatens to significantly reduce federal Medicaid spending. According to reports, approximately 11.8 million Americans are expected to lose Medicaid coverage by 2034, with 5.2 million affected by new work requirements alone. To curb state-level Medicaid expenditures, the bill gradually limits the use of 'provider taxes' as a revenue source. However, it also allocates $50 billion in funding to support rural hospitals impacted by these cuts. While insurers like UnitedHealth and Humana Inc. HUM may encounter short-term pressure from shrinking Medicaid rolls, they could ultimately benefit as displaced members shift toward private coverage options. UnitedHealth's Medicaid membership declined 4% in 2023, 5.2% in 2024, and 1.4% in the first quarter of 2025. The proposed elimination of ACA marketplace tax credits will likely propel more people into employer-sponsored plans. Meanwhile, Medicare Advantage may gain traction, as seniors grapple with increased out-of-pocket expenses due to rollbacks in Medicare Savings Programs. UnitedHealth's Medicare Advantage enrollment rose by 8.3% in 2023, 1.9% in 2024, and 6.3% in the first quarter of 2025. Another major development shook the market as Centene Corporation CNC, a major Medicaid player, withdrew its 2025 earnings guidance late Tuesday, citing unexpected enrollment shifts and higher medical costs. The move, mirroring UnitedHealth's earlier decision, rattled the managed care sector. Centene shares witnessed massive declines following the news, and peers like UnitedHealth and Humana followed suit. Centene shares plummeted 41.2% following the announcement, dragging down peers: UnitedHealth and Humana dropped 5.4% and 5.1%, respectively, despite broader market gains driven by tech strength and encouraging jobs data. Image Source: Zacks Investment Research From a valuation standpoint, UnitedHealth trades at a forward price-to-earnings ratio of 12.99, up from the industry average of 11.49. UNH currently carries a Value Score of A. Image Source: Zacks Investment Research The Zacks Consensus Estimate for UnitedHealth's 2025 earnings is pegged at $22.07 per share, implying a 20.2% drop from the year-ago period. Image Source: Zacks Investment Research The stock currently carries a Zacks Rank #5 (Strong Sell). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report Humana Inc. (HUM) : Free Stock Analysis Report Centene Corporation (CNC) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
9 hours ago
- Yahoo
Molina Healthcare's Q2 2025 Earnings: What to Expect
Long Beach, California-based Molina Healthcare, Inc. (MOH) provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. With a market cap of $16.6 billion, the company operates in four segments: Medicaid, Medicare, Marketplace, and Other. The healthcare company is poised to report its fiscal 2025 Q2 earnings on Wednesday, July 23, after the market closes. Ahead of this event, analysts expect the company to report a profit of $6.12 per share, up 4.4% from $5.86 per share in the year-ago quarter. The company has surpassed the Street's bottom-line projections in three of the past four quarters, while missing on one occasion. Is UnitedHealth Stock a Buy, Sell, or Hold for July 2025? Michael Saylor Says 'You'll Wish You'd Bought More' Bitcoin as MicroStrategy Doubles Down Is MicroStrategy Stock a Buy, Sell, or Hold for July 2025? Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! For fiscal 2025, analysts expect MOH to report a profit of $24.43, up 7.9% from $22.65 in fiscal 2024. Furthermore, its EPS is expected to grow 14.7% year over year to $28.03 in fiscal 2026. MOH stock has declined 18.2% over the past 52 weeks, underperforming the Health Care Select Sector SPDR Fund's (XLV) 6.3% decline and the S&P 500 Index's ($SPX) 13% uptick during the same time frame. Molina Healthcare stock fell 5.5% following the release of its Q1 earnings on Apr. 23. The company's revenue came in at $11.2 billion, increasing 12.2% from the year-ago quarter, and beating the Street forecasts. Moreover, its adjusted EPS came in at $6.08, up 6.1% year-over-year, and surpassed the consensus estimates by 3.8%. Wall Street analysts are moderately optimistic about MOH's stock, with a "Moderate Buy" rating overall. Among 16 analysts covering the stock, six recommend "Strong Buy," one suggests 'Moderate Buy,' eight advise 'Hold,' and one suggests 'Moderate Sell.' MOH's average analyst price target of $358.64 indicates a potential upside of 50.1% from the current levels. On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data